Mazen Noureddin Selected Research

belapectin

4/2021	Review of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis.
1/2020	Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mazen Noureddin Research Topics

Disease

49	Non-alcoholic Fatty Liver Disease 11/2022 - 09/2012
37	Fibrosis (Cirrhosis) 11/2022 - 10/2010
10	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 12/2018
10	Liver Diseases (Liver Disease) 04/2022 - 09/2016
10	Inflammation (Inflammations) 01/2022 - 11/2013
9	Fatty Liver 01/2022 - 01/2017
6	Insulin Resistance 01/2022 - 06/2015
6	Infections 03/2017 - 01/2012
5	Pruritus (Itching) 06/2022 - 01/2020
5	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 04/2012
5	Obesity 01/2022 - 05/2015
5	Hepatitis C 03/2018 - 10/2011
4	Liver Neoplasms (Liver Cancer) 11/2022 - 03/2007
4	Weight Loss (Weight Reduction) 01/2022 - 09/2017
4	Alcoholic Fatty Liver 01/2022 - 02/2020
4	Neoplasms (Cancer) 09/2021 - 01/2017
4	Chronic Hepatitis C 01/2014 - 09/2010
3	Disease Progression 11/2022 - 09/2017
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 06/2015
3	Endotoxemia 10/2020 - 10/2008
3	End Stage Liver Disease 01/2020 - 03/2017
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 06/2022 - 10/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2020
2	Body Weight (Weight, Body) 01/2022 - 12/2013
2	Overweight 01/2022 - 10/2019
2	Dysbiosis 01/2022 - 10/2020
2	Fatigue 07/2021 - 02/2020
2	Varicose Veins (Varicose Vein) 04/2021 - 01/2020
2	Esophageal and Gastric Varices (Esophageal Varices) 04/2021 - 01/2020
2	Portal Hypertension 01/2021 - 01/2020
2	Cholestasis 02/2020 - 01/2018
2	Cholangiocarcinoma 01/2018 - 01/2017
1	Sclerosing Cholangitis 06/2022
1	COVID-19 05/2022
1	Lipodystrophy 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Wolman Disease (Wolman's Disease) 01/2022

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 11/2022 - 09/2012
8	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2015
7	Alanine Transaminase (SGPT)IBA 10/2021 - 11/2013
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2022 - 11/2013
6	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 12/2018
5	nasIBA 10/2022 - 01/2019
5	cilofexorIBA 06/2022 - 01/2020
5	firsocostatIBA 01/2022 - 11/2018
5	Pharmaceutical PreparationsIBA 01/2022 - 07/2015
5	S-Adenosylmethionine (Ademetionine)IBA 01/2022 - 10/2008
5	Antiviral Agents (Antivirals)IBA 11/2018 - 01/2012
5	Ribavirin (Virazole)FDA LinkGeneric 10/2014 - 09/2010
5	InterferonsIBA 10/2014 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2012
4	Transaminases (Aminotransferases)IBA 01/2022 - 09/2016
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2018
4	LipidsIBA 01/2022 - 01/2021
3	EnzymesIBA 10/2022 - 06/2015
3	Protons (Proton)IBA 04/2022 - 11/2018
3	Insulin (Novolin)FDA Link 01/2022 - 01/2018
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 06/2019
2	RNA (Ribonucleic Acid)IBA 05/2022 - 11/2013
2	SodiumIBA 01/2022 - 03/2017
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2007
2	Methionine (L-Methionine)FDA Link 01/2022 - 11/2017
2	semaglutideIBA 01/2022 - 01/2022
2	Fibric Acids (Fibrates)IBA 01/2022 - 02/2020
2	LipopolysaccharidesIBA 01/2022 - 10/2020
2	obeticholic acidIBA 01/2022 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2021 - 01/2020
2	Drug CombinationsIBA 07/2021 - 01/2021
2	selonsertibIBA 07/2021 - 01/2021
2	belapectinIBA 04/2021 - 01/2020
2	Galectin 3 (LGALS3)IBA 04/2021 - 01/2020
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2021
2	Vitamin D FDA LinkGeneric 10/2020 - 01/2020
2	DefensinsIBA 10/2020 - 01/2020
2	Biological ProductsIBA 10/2020 - 01/2020
2	Coffee FDA Link 05/2020 - 01/2017
2	InterleukinsIBA 11/2013 - 04/2012
1	very low density lipoprotein triglycerideIBA 10/2022
1	Phospholipases (Phospholipase)IBA 10/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	Pioglitazone (Actos)FDA Link 01/2022
1	ribosomal protein S3IBA 01/2022
1	Vitamin E FDA LinkGeneric 01/2022
1	SugarsIBA 01/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	FructoseIBA 01/2022
1	Liraglutide FDA Link 01/2022
1	Fetal Proteins (Fetoprotein)IBA 01/2022
1	ribosomal protein L18IBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	AngiotensinsIBA 01/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022

Therapy/Procedure

23	Therapeutics 06/2022 - 10/2010
16	Liver Transplantation 11/2022 - 07/2015
2	Bariatric Surgery 01/2022 - 09/2017
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
1	Continuity of Patient Care 05/2022